Lymphovascular space invasion as a prognostic factor of epithelial ovarian cancer: a multicenter study by the FRANCOGYN group.

Date publication

juin 2021

Journal

Archives of gynecology and obstetrics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles , Pr AKLADIOS Chérif

Tous les auteurs :
Lorenzini J, Cirier J, Body G, Touboul C, Dabi Y, Collinet P, Coutant C, Akladios C, Lavoué V, Bolze PA, Huchon C, Bricou A, Canlorbe G, Ballester M, Carcopino X, Mimoun C, Bendifallah S, Ouldamer L,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34184114

Résumé

The presence of lymphovascular space invasion (LVSI) is not yet included in international recommendations neither as a prognostic factor nor as a parameter for the decision to use adjuvant chemotherapy in FIGO stage I/IIa ovarian cancer (OC).

Mots clés

Lymphovascular space invasion, Ovarian cancer, Overall Survival, Prognosis, Recurrence-Free Survival

Référence

Arch Gynecol Obstet. 2021 Jun 29;: